I'm Vivian Wohl, Portfolio Manager, Federated Hermes.
Where are you finding opportunities?
Well, I think the companies that have been the most nimble companies in the software space have been able to adapt. For example, in helping pharmaceutical companies keep their clinical trials on track, they're helping the CROs find new ways to monitor the trials, to get the patient feedback that they need to for the trials to be valid, to collect enough data for the FDA. Some companies are also being really innovative in enabling the pharmaceutical sales forces in the country to still remain connected to their customers, to their physicians. So that's exciting. And I think everybody's looking forward to getting back and seeing their customers in person, but I think to some extent that flexibility of being able to share more content online, I think that is gonna stay with us. So I think that is really exciting.
Disclosure: Views are as of July 8, 2020 and are subject to change based on market conditions and other factors. These views should not be construed as a recommendation for any specific security or sector. Investing in IPOs involves special risks such as limited liquidity and increased volatility. Federated Global Investment Management Corp. 20-30303 (7/20)